Patrick Cox: Tax the rich, bring back the guillotine! May 8, 2026 Iconic 90s shoe designer Patrick Cox, and soon-to-be Cordwainer, takes us on a trip down memory lane in this week's Square Mile and Me.
AngloGold Ashanti Q1 31 March 2026 Earnings Release and Dividend Declaration May 8, 2026 AngloGold Ashanti delivers record free cash flow* of $1.2bn and EBITDA*(4) of $2.3bn • Gold production(1)(2) +1% • Net cash*(4) of $868m • Q1 2026 interim dividend of $585m, or 116 cps • Proposed $2.0bn share repurchase programme announced
In defence of Bristol Bears CEO Tom Tainton’s rugby marketing comments May 8, 2026 “At Bristol Bears, we don’t call ourselves a rugby club. We are a marketing agency that plays rugby. Yes, our players have to be competent and able to deliver on the field, but if they are not bringing any value off the field, that genuinely factors into our recruitment conversations.” Those were the words of [...]
Drill baby brill: Why the UK must develop it’s North Sea oil fields May 8, 2026 In light of international crises like the war in Iran and the resulting energy price spikes, the UK’s fundamental energy vulnerability – its dependence on a volatile international market – can be solved by immediately approving further drilling in the North Sea, says Brandon Lewis Moments of crisis have a clarifying power that peacetime politics [...]
Prothena Reports First Quarter 2026 Financial Results and Business Highlights May 7, 2026 Net cash provided by operating and investing activities was $28.9 million for the first quarter of 2026; quarter-end cash and restricted cash position was $330.3 million Prothena updates projected full year 2026 net cash used in operating and investing actives to be $18 to $23 million (versus prior guidance $50 to $55 million) and expects to end the year with approximately $273 million (midpoint) in cash, cash equivalents and restricted cash Novo Nordisk obtained Fast Track designation from the U.S. FDA for coramitug (PRX004) for the treatment of ATTR amyloidosis with cardiomyopathy and paid Prothena a $50 million clinical milestone payment related to Phase 3 enrollment Roche presented several clinical updates supporting the potential of prasinezumab for the treatment of Parkinson’s disease at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2026) Prothena has completed the Phase 1 study for PRX019. Prothena could potentially earn a $55 million clinical milestone payment if Bristol Myers Squibb decides to advance the program; BMS decision expected by year-end 2026 Prothena initiated a share repurchase program to be conducted in 2026 for up to $100 million if deemed appropriate
Sky Vegas Free Spins 2026: Sky Vegas Welcome Offer UK May 7, 2026 Sky Vegas is one of the most recognisable names in online casino gaming, backed by the trusted Sky brand that UK players have known for decades. In this review, we cover everything you need to know about the Sky Vegas welcome offer, the casino games library, payment methods, and overall platform experience. Claim your Sky [...]
Herald trust saved after Saba and Aberdeen ink deal May 7, 2026 Aberdeen and US activist hedge fund Saba have reached agreement for the Scottish investment juggernaut to manage Herald Investment Trust, ending a years-long arm wrestle over the trust’s future. In an eleventh-hour deal that will save Herald from being wound down, Aberdeen will recruit eight of the fund’s staff – including fund manager Katie Potts [...]
New London rooftop bar will be biggest ever with 1,000 capacity May 7, 2026 Getting a reservation at London’s most famous rooftop bars can be difficult, especially with the better weather. New London rooftop bar Freight Brixton will attempt to remedy that issue with room for 1,000 at the open-air venue. The bar will offer drinking, dancing and dining, with DJs spinning funk, jazz and soul tunes throughout the [...]
Grosvenor estate: Ministers don’t get ‘basic economics’ May 7, 2026 The Duke of Westminster’s multi-billion pound estate has chided ministers for failing to grasp “basic economics” in their bid to tackle the housing crisis. Mark Preston, who represents the business interests of Hugh Grosvenor, the seventh Duke of Westminster and owner of a Mayfair property empire, said the government risks choking housing supply if it [...]
Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results May 7, 2026 Phase 2 SANRECO trial of divesiran, a first-in-class siRNA for polycythemia vera (PV), on-track for topline results in August 2026